cyclazosin

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug Namecyclazosin
Drug Alias Namecyclazosin
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAlpha-1a adrenergic receptor antagonists
TargetsAlpha-1a adrenergic receptor
Therapy Area/IndicationsHypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItaly
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity of Camerino
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity of Camerino
Active IndicationsN/A
Inactive IndicationsHypertension

Other Information

ATC CodeN/A
Related LinksN/A